• Last updated：2024-08-13
• Count Views：729

The CDE's Index Case Consultation, established in 2005, offers domestic biotech and pharmaceutical companies as well as medical institutions and academia regulatory advice throughout the development stages. A dedicated team is formed for each case, ensuring in-depth, proactive support that shortens timelines and reduces costs for drug development. Additionally, applicants are welcome to explore the CDE's "Paid Consultations" program launched in January 2018.